[Disorders of hemostasis caused by dipropylacetate].
D001791:Blood Platelet Disorders / Q000139:chemically induced*; D002648:Child; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced*; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D005260:Female; D006461:Hemolysis / Q000187:drug effects; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D014631:Valerates / Q000009:adverse effects*; D014635:Valproic Acid / Q000009:adverse effects* / Q000627:therapeutic use
D014631:Valerates; D014635:Valproic Acid
Zur Frage der Hämostase-Störung durch Dipropylazetat